Skip to main
SONN
SONN logo

Sonnet BioTherapeutics (SONN)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Sonnet BioTherapeutics (SONN) Stock

About Sonnet BioTherapeutics (SONN)

Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its pipeline focuses on cytokines, a class of cell signaling peptides that, among othe...read more
Market cap$14.69M
Yesterday's volume741
Revenue (TTM)$1M
Avg. daily volume2.84M
EBITDA (TTM)-$13.68M
Open$4.52
Price / earnings ratio-0.36x
Yesterday's range$4.32 - $5.1
Debt / equity13.66x
52 week range$1.08 - $10.02
5 year debt / equity-13.42x
Beta (LTM)0.46x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio1.03x
Ex-dividend date
Next earningsAug 13, 2025
Dividend payable date

Sonnet BioTherapeutics Stock Rating

What analysts recommend for SONN stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jul 09, 2025, the market cap for SONN stock is $14.69M

The current P/E ratio for SONN stock is -0.36

The 52-week high for SONN stock is $10.02. The current SONN stock price $undefined is 100.00% below its 52-week high

The 52-week low for SONN stock is $1.08. The current SONN stock price $undefined has increased 100.00% from its 52-week low

No, the SONN stock does not pay dividends to its shareholders

The target price for SONN stock is $7.60 based on the average of what a group of analyst think SONN stock could be worth at a future date. This is not a prediction by Public.com

How to buy SONN stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in SONN stock

    Navigate to the Explore page. Then, type SONN into the search bar. When you see SONN stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased SONN stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Sonnet BioTherapeutics Stock Earnings

The value each SONN share was expected to gain vs. the value that each SONN share actually gained.

Sonnet BioTherapeutics (SONN) reported Q2 2025 earnings per share (EPS) of -$0.89, missing estimates of -$0.79 by 12.66%. In the same quarter last year, Sonnet BioTherapeutics's earnings per share (EPS) was $0.56. Sonnet BioTherapeutics is expected to release next earnings on 08/13/2025, with an earnings per share (EPS) estimate of $0.

Buy Sonnet BioTherapeutics (SONN) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.